MARKET

MTEM

MTEM

Molecular US
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.71
-0.26
-1.86%
After Hours: 13.71 0 0.00% 16:29 01/17 EST
OPEN
14.07
PREV CLOSE
13.97
HIGH
14.42
LOW
13.58
VOLUME
224.72K
TURNOVER
--
52 WEEK HIGH
15.05
52 WEEK LOW
4.070
MARKET CAP
601.25M
P/E (TTM)
-8.4002
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MTEM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MTEM News

  • The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
  • Benzinga.5d ago
  • The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx
  • Benzinga.01/10 12:13
  • Molecular Templates Provides Corporate Update and Outlines 2020 Milestones
  • GlobeNewswire.01/08 13:00
  • Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus
  • Benzinga.12/29/2019 23:38

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About MTEM

Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. The Company also focused on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies (ETBs). The Company is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. The Company’s lead drug candidate MT-3724 is an is an immunotoxin that targets the CD20 cell surface antigen present in a variety of lymphomas and leukemias.
More

Webull offers Molecular Templates Inc (MTEM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.